News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
145–180
Matches
576
Sources here
26
Companies here
13
Search results Stored financial headlines

Active search

576 matching headlines

Ticker or company: ALYMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

QUALYS, INC. : RBC RAISES TARGET PRICE TO $180 FROM $145

RBC has increased its target price for Qualys, Inc. (QUALYS) from $145 to $180. This indicates a positive outlook from the firm regarding Qualys's future stock performance. The report was issued by Reuters.

QLYS main company
Sharemaestro market context Trend signal active 52 weeks +38.3% QLYS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Sei Investments Co. Purchases 10,569 Shares of Qualys, Inc. $QLYS

Sei Investments Co. increased its stake in Qualys, Inc. (NASDAQ:QLYS) by 28.8% in the first quarter, purchasing an additional 10,569 shares to own a total of 47,295 shares valued at $4.155 million. Several other hedge funds also adjusted their positions in Qualys, with institutional …

QLYS main company
Sharemaestro market context Trend signal active 52 weeks +38.3% QLYS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Health Catalyst (Nasdaq: HCAT) sells Vitalware, ends credit facility debt

Health Catalyst (HCAT) has completed the sale of its Vitalware business to Med-Metrix for $147 million, using the proceeds to fully repay its credit facility debt of $159.9 million. This move is expected to eliminate approximately $19 million in annual interest expenses and will …

HCAT main company
Sharemaestro market context Trend signal active 52 weeks -43.6% · Next-week setup negative 44.5% HCAT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Health Catalyst (NASDAQ: HCAT) books $151.6M loss and $147M Vitalware sale

Health Catalyst, Inc. (NASDAQ: HCAT) reported a net loss of $151.6 million for the first half of 2026, primarily due to a $122.5 million goodwill impairment charge. The company also announced the sale of its Vitalware business to Med-Metrix for $147 million, with the …

HCAT main company
Sharemaestro market context Trend signal active 52 weeks -43.6% · Next-week setup negative 44.5% HCAT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Health Catalyst, Inc. 2026: Revenue $70.49M, EPS ($0.55) — 10-Q Summary

Health Catalyst, Inc. (HCAT) reported Q3 2026 revenue of $70.49 million, a decline from $80.72 million in the prior year, and a net loss of ($0.55) per diluted share. The company attributes the revenue drop to customer churn from DOS-to-Ignite migrations and the exit …

HCAT main company
Sharemaestro market context Trend signal active 52 weeks -43.6% · Next-week setup negative 44.5% HCAT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

FMR LLC reports 5.1% Mineralys Therapeutics (MLYS) stake in amended ownership filing

FMR LLC has filed an amended Schedule 13G, disclosing a beneficial ownership of 5.1% in Mineralys Therapeutics, Inc. (MLYS), which accounts for 4,461,689.46 shares of common stock. The filing specifies that FMR LLC holds sole voting power over 4,461,164.00 shares and sole dispositive power …

MLYS main company
Sharemaestro market context Price below Trend Line 52 weeks +72.3% MLYS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Press Release: Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company

Health Catalyst has announced the completion of the sale of its Vitalware business to RLDatix. This strategic move allows Health Catalyst to sharpen its focus on its core healthcare intelligence and analytics offerings, streamlining its operations and strengthening its balance sheet. The company anticipates …

HCAT main company
Sharemaestro market context Trend signal active 52 weeks -43.6% · Next-week setup negative 44.5% HCAT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings call transcript: Health Catalyst posts Q2 2026 revenue beat, shares sink

Health Catalyst (HCAT) reported Q2 2026 revenue above Wall Street expectations, reaching $70.5 million, and adjusted EBITDA at the high end of guidance. However, the company's shares sank by over 27% in after-hours trading due to a weaker full-year outlook, which was primarily impacted …

HCAT main company
Sharemaestro market context Trend signal active 52 weeks -43.6% · Next-week setup negative 44.5% HCAT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Health Catalyst (NASDAQ:HCAT) Exceeds Q2 CY2026 Expectations But Stock Drops 25.5%

Health Catalyst (NASDAQ:HCAT) reported Q2 CY2026 results that surpassed revenue expectations but showed a 12.7% year-on-year sales decline. Despite exceeding revenue and adjusted EBITDA estimates, the company's stock dropped 25.5% due to lower-than-expected revenue guidance for the next quarter and the full year, along …

HCAT main company
Sharemaestro market context Trend signal active 52 weeks -43.6% · Next-week setup negative 44.5% HCAT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

M&A: Health Catalyst Closes $147M Sale of Vitalware to Med-Metrix

Health Catalyst, a healthcare intelligence company, has completed the sale of its mid-revenue cycle business, Vitalware, to Med-Metrix for $147 million. This divestiture allows Health Catalyst to repay its credit facility, eliminating approximately $19 million in annual interest expense, and focus its capital and …

HCAT main company
Sharemaestro market context Trend signal active 52 weeks -43.6% · Next-week setup negative 44.5% HCAT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

HEALTH CATALYST ($HCAT) Releases Q2 2026 Earnings

HEALTH CATALYST ($HCAT) announced its Q2 2026 earnings, reporting $0.04 per share, beating estimates by $0.01, and revenue of $70.49 million, surpassing estimates. Despite strong earnings, the stock price decreased by 27.83% since market close. The article also details recent hedge fund activity in …

HCAT main company
Sharemaestro market context Trend signal active 52 weeks -43.6% · Next-week setup negative 44.5% HCAT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Health Catalyst Reports Second Quarter 2026 Results

Health Catalyst (Nasdaq: HCAT) reported its financial results for the second quarter ended June 30, 2026, exceeding revenue guidance and adjusting EBITDA. The company's CEO, Ben Albert, highlighted the Vitalware divestiture and debt repayment as significant balance sheet improvements. Health Catalyst also provided its …

HCAT main company
Sharemaestro market context Trend signal active 52 weeks -43.6% · Next-week setup negative 44.5% HCAT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Quantinno Capital Management LP Has $6.85 Million Stock Position in Annaly Capital Management Inc $NLY

Quantinno Capital Management LP significantly increased its stake in Annaly Capital Management (NLY) by 123.7% in the first quarter, holding over 323,924 shares valued at $6.85 million. Other institutions, including Goldman Sachs, also boosted their positions, contributing to 51.56% institutional ownership. Annaly reported strong …

NLY main company
Sharemaestro market context Trend signal active 52 weeks +21.7% NLY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Health Catalyst Tries To Reset With A Vitalware Sale

Health Catalyst (HCAT) plans to sell its Vitalware product line for $147 million to reduce debt and improve margins, aiming to refocus on its higher-growth Ignite platform and AI-enabled solutions. While the company faces significant operating losses and negative returns on invested capital, the …

HCAT main company
Sharemaestro market context Trend signal active 52 weeks -43.6% · Next-week setup negative 44.5% HCAT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cargo Theft Losses More Than Double to $304 Million in Q2

Cargo theft losses more than doubled to $304.6 million in Q2 2026, despite a 26% decrease in the number of incidents, according to Verisk CargoNet. This surge in financial impact is attributed to a rise in sophisticated thefts targeting high-value commodities like metals and …

VRSK main company
Sharemaestro market context Price below Trend Line 52 weeks -32.4% VRSK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cargo theft incidents fell 26%, but estimated losses hit $304.6M in Q2

Verisk's CargoNet reported a 26% decrease in cargo and supply chain theft incidents in Q2 2026, totaling 677 events in the U.S. and Canada. Despite fewer incidents, estimated losses more than doubled year-over-year to $304.6 million, driven by high-value metals and enterprise technology thefts. …

VRSK main company
Sharemaestro market context Price below Trend Line 52 weeks -32.4% VRSK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Best Value Stocks to Buy for August 6th

This article identifies three top value stocks for August 6th, all carrying a Zacks Rank #1 (Strong Buy). The selected companies are Annaly Capital Management, Inc. (NLY), Industrial and Commercial Bank of China Limited (IDCBY), and Agricultural Bank of China Limited (ACGBY). Each stock …

NLY main company
Sharemaestro market context Trend signal active 52 weeks +21.7% NLY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BofA Securities Maintains Annaly Capital Management Inc(NLY.US) With Hold Rating, Maintains Target Price $22.5

BofA Securities has reiterated its Hold rating on Annaly Capital Management Inc. (NLY.US) and maintained its price target of $22.5. This indicates a neutral outlook on the company's stock performance.

NLY main company
Sharemaestro market context Trend signal active 52 weeks +21.7% NLY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Why Qualys Stock Crushed it on Wednesday

Key Points Both revenue and profitability were notably above the consensus analyst estimates. The company's full-year guidance anticipates continued growth.10 stocks we like better than Qualys › Shares of cybersecurity company Qualys(NASDAQ: QLYS) looked more than secure on Hump Day, thanks to strong second-quarter …

QLYS main company
Sharemaestro market context Trend signal active 52 weeks +38.3% QLYS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Verisk Analytics Inc. stock underperforms Wednesday when compared to competitors

Shares of Verisk Analytics Inc. (VRSK) dropped 2.10% on Wednesday, closing at $188.75. This decline occurred during a mixed trading session where the Dow Jones Industrial Average rose, but the S&P 500 Index fell. This marks the stock's fifth consecutive day of losses.

VRSK main company
Sharemaestro market context Price below Trend Line 52 weeks -32.4% VRSK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Qualys (QLYS) Soars As Earnings Beat And AI Security Push Ignite Rally

Qualys (QLYS) shares rallied 15.8% after reporting strong Q2 earnings, beating analyst expectations on both revenue and EPS, and raising its full-year guidance. The company's push into AI security with new tools like InstaScan and broader TotalAI capabilities, coupled with its robust financial performance, …

QLYS main company
Sharemaestro market context Trend signal active 52 weeks +38.3% QLYS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Verisk (VRSK) CIO Change Hands CTO Interim Role After Nick Daffan Steps Down

Verisk Analytics (VRSK) announced that EVP and CIO Nick Daffan is stepping down after two decades, with the company's CTO assuming interim CIO responsibilities. This leadership change occurs as Verisk focuses heavily on AI, cloud infrastructure, and advanced analytics, amidst strong Q2 2026 results …

VRSK main company
Sharemaestro market context Price below Trend Line 52 weeks -32.4% VRSK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CLST's Q2 Earnings Flat Y/Y, Merger Costs and Loan Weakness Hurt

Catalyst Bancorp, Inc. (CLST) reported flat Q2 2026 earnings per share year-over-year, impacted by higher operating costs including merger-related expenses, despite a rise in net interest income. The company saw an increase in total assets and deposits, but net loans receivable declined, though credit …

CLST main company
Sharemaestro market context Trend signal active 52 weeks +36.0% · Next-week setup positive 56.9% CLST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Qualys stock hits 52-week high at $200.57

Qualys (QLYS) stock reached a new 52-week high of $200.57, reflecting strong market confidence and growth in the cybersecurity sector. Despite being considered overvalued by InvestingPro analysis, the company reported better-than-expected Q2 revenue and profit, leading to a raised full-year outlook. This performance highlights …

QLYS main company
Sharemaestro market context Trend signal active 52 weeks +38.3% QLYS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context